These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9732842

  • 1. [Tissue polypeptide antigen and carcinoembryonic antigen in bladder neoplasms].
    Krajewska B, Stelmach W, Lutz W, Matych J.
    Med Pr; 1995; 46(1):7-16. PubMed ID: 9732842
    [Abstract] [Full Text] [Related]

  • 2. Determination of tissue polypeptide antigens (TPA) and carcinoembryonic antigen (CEA) in serum: its value in the preliminary cancer risk assessment in asbestos exposed workers.
    Lutz W, Krajewska B, Piłacik B.
    Int J Occup Med Environ Health; 1997; 10(3):259-65. PubMed ID: 9524403
    [Abstract] [Full Text] [Related]

  • 3. [Changes in the levels of tissue polypeptide antigen and carcinoembryonic antigen in the blood of workers exposed to aromatic amines].
    Lutz W, Krajewska B.
    Med Pr; 1992; 43(4):297-301. PubMed ID: 1453945
    [Abstract] [Full Text] [Related]

  • 4. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR, Zhang X, Xu ZF, Zheng S.
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
    Vogel J, Oehr P, Maisey R, Adolphs HD.
    Cancer Detect Prev; 1988 Feb; 11(3-6):389-96. PubMed ID: 2455597
    [Abstract] [Full Text] [Related]

  • 7. [Advances regarding tumor markers in bladder cancer].
    Moreno Sierra J, Chicharro Almarza GJ, Torronteras Santiago JM, Ortega Heredia MD, Maestro de las Casas ML, Silmi Moyano A, Resel Estévez L.
    Actas Urol Esp; 1997 Mar; 21(3):195-205. PubMed ID: 9324884
    [Abstract] [Full Text] [Related]

  • 8. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
    Ecke TH, Lenk SV, Schlechte HH, Loening SA.
    Anticancer Res; 2003 Mar; 23(2A):957-62. PubMed ID: 12820330
    [Abstract] [Full Text] [Related]

  • 9. [Exposure to asbestos and levels of selected tumor biomarkers].
    Krajewska B, Lutz W, Piłacik B.
    Med Pr; 1996 Mar; 47(2):89-96. PubMed ID: 8657007
    [Abstract] [Full Text] [Related]

  • 10. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R, Albrecht S, Richter B, Deutschmann K, Zimmermann T, Distler W.
    Luminescence; 2000 Mar; 15(5):283-9. PubMed ID: 11038485
    [Abstract] [Full Text] [Related]

  • 11. Relationship between tissue and serum concentrations of carcinoembryonic antigen (CEA) in gastric and colonic carcinomas.
    Rosandić-Pilas M, Hadzić N, Stavljenic A, Juricić M, Scukanec-Spoljar M.
    Acta Med Austriaca; 1990 Mar; 17(5):89-93. PubMed ID: 2092570
    [Abstract] [Full Text] [Related]

  • 12. Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer.
    Tuxen MK, Sölétormos G, Petersen PH, Schioler V, Dombernowsky P.
    Gynecol Oncol; 1999 Jul; 74(1):12-22. PubMed ID: 10385546
    [Abstract] [Full Text] [Related]

  • 13. [Usefulness of biological tumor markers for early detection of neoplastic changes in the bladder of persons exposed to aromatic amines].
    Hanke J, Krajewska B, Lutz W.
    Med Pr; 1989 Jul; 40(6):376-80. PubMed ID: 2698439
    [Abstract] [Full Text] [Related]

  • 14. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR, Lee WJ, Huang MT, Lin HH.
    Hepatogastroenterology; 2002 Jul; 49(46):1157-60. PubMed ID: 12143226
    [Abstract] [Full Text] [Related]

  • 15. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P, Fornier M, Miceli R, Seregni E, Santambrogio L, Nosotti M, Cataldo I, Sala M, Caldiera S, Bombardieri E.
    Anticancer Res; 1999 Jul; 19(4C):3613-8. PubMed ID: 10629660
    [Abstract] [Full Text] [Related]

  • 16. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N.
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K, Yonese Y, Nakagami Y, Minowa T, Hiraoka Y, Yamada N, Hikima N, Ishii Y, Tannowa K, Fujioka Y.
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical effectiveness of tumor markers in squamous cell carcinoma of the larynx.
    Eleftheriadou A, Chalastras T, Ferekidou E, Kyriou L, Yiotakis I, Pappas Z, Ferekidis E, Kandiloros D.
    Anticancer Res; 2006 May; 26(3B):2493-7. PubMed ID: 16821638
    [Abstract] [Full Text] [Related]

  • 20. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E, Jotti GS, Cocciolo MG, Mori M, Rusconi A, Rusca M, Seregni E, Becchi G, Fontanesi M, Tardini A.
    Cancer Detect Prev; 1985 May; 8(1-2):219-26. PubMed ID: 4064041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.